跳至主要内容
临床试验/NCT07362303
NCT07362303尚未招募不适用

Neuralert Stroke Monitor Trial

Neuralert Technologies LLC0 个研究点目标入组 1,200 人开始时间: 2026年1月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
1,200
主要终点
Efficacy of Device

研究概览

简要总结

The Neuralert monitoring system, a non-invasive device worn on each wrist, is designed to provide continuous monitoring and expedited recognition of stroke by identifying asymmetry in the extremities, facilitating patient treatment and improving outcomes. This study is designed to evaluate the safety and effectiveness of the Neuralert Monitor. This study aims to show that the device produces fewer than 2 false alarms per patient per day on average, and that the device detects stroke with a sensitivity significantly greater than a device producing 2 random alerts per day.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (all must be yes)
  • Male or female age ≥ 22 years
  • Admitted or planned admission to one of the participating hospitals and followed by the Cardiothoracic (CT) Surgery or Vascular Surgery services
  • Considered at high risk for stroke while in the hospital based on:
  • Interventions or procedures that are high-risk for stroke performed during the hospitalization, which may include:
  • Intracardiac surgical or endovascular procedures, including valve replacement
  • Ascending aorta or aortic arch surgical or endovascular repair
  • Open surgical or endovascular carotid revascularization
  • Other cardiac procedures along with a high-risk medical history:
  • Age ≥ 80 years
  • Prior stroke/ transient ischemic attack (TIA)
  • Hypercoagulable state (i.e., prior clotting events attributed to active malignancy or a diagnosed thrombophilia) requiring lifelong anticoagulation
  • Severely reduced left ventricular cardiac ejection fraction (i.e., <30%) or anterior left ventricular wall akinesis
  • Atrial fibrillation

排除标准

  • (all must be no)
  • Any medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's safety or successful participation in the study
  • Baseline preoperative asymmetric upper extremity weakness as assessed by the Investigator, defined as a differential in the NIHSS upper extremity motor score between the two arms of >0
  • Above the wrist amputation
  • Unwilling to provide informed consent or no legally authorized representative willing to provide consent if the patient is unable
  • Currently imprisoned

研究组 & 干预措施

Cardiac Surgery Patients

Experimental

Device: Neuralert Monitor Device to identify upper extremity asymmetry in patients who are high risk for stroke.

干预措施: Neuralert Monitor (Device)

结局指标

主要结局

Efficacy of Device

时间窗: through study completion, an average of 2 years

To show that the sensitivity of the Neuralert Monitor exceeds the specified performance goal, and

Safety of Device

时间窗: through study completion, an average of 2 years

To show that the mean number of false alarms/patient/day for the Neuralert Monitor is less than the specified performance goal.

次要结局

  • Length of time to detection of any stroke(through study completion, an average of 2 years)
  • Length of time to detection of stroke by Neuralert(through study completion, an average of 2 years)
  • Number of alerts caused by stroke (PPV)(through study completion, an average of 2 years)

研究者

发起方
Neuralert Technologies LLC
申办方类型
Industry
责任方
Sponsor

相似试验